Patricia A Robinson

Associate Professor in the Department of Medicine, Division of Hematology and Oncology at Northwestern University Feinberg School of Medicine. Specializes in breast cancer research with focus on metastatic disease, immunotherapy, and nutritional impacts on outcomes. Affiliated with the Robert H. Lurie Comprehensive Cancer Center.

Education:

• Board Certified in Medical Oncology, Northwestern University

Research centers on breast cancer subtypes, particularly hormone receptor-positive and triple-negative metastatic disease. Investigates immune biomarkers for immunotherapy response, body composition impacts on survival, and nutritional interventions like vitamin D supplementation. Leads clinical trials exploring novel neoadjuvant combinations including immunotherapy and metabolic agents.

Current leadership roles include Co-chair of Big Ten Cancer Research Consortium (breast focus), advisor to SWOG Vice Chair for Diversity, Equity and Inclusion, and President of Equal Hope. Serves on NCCN-Pfizer metastatic breast cancer project and previously chaired Education Committee.

Professional Affiliations:

• American Society of Clinical Oncology (1999-Present)
• Southwest Oncology Group (SWOG) (2023-Present)
• Cancer Support Community (2013-Present)

Principal Investigator for active clinical trials including SWOG 2206 (durvalumab + chemotherapy for MammaPrint Ultrahigh breast cancer). Industry collaborations include Merck & Co. and Pfizer for educational activities.